Engineers Gate Manager LP Biotechnology

Engineers Gate Manager LP

$5.42 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
RVPH Reviva Pharmaceuticals Holdings, Inc.	$28.6M	$59,000 0.0% of portfolio	34,581	Q4 2024 New
VTYX Ventyx Biosciences, Inc.	$82M	$58,000 0.0% of portfolio	26,797	Q4 2024 New
SGMO Sangamo Therapeutics, Inc	$150M	$56,000 0.0% of portfolio	54,939	Q4 2024 Added 20.9%
ZNTL Zentalis Pharmaceuticals, Inc.	$115M	$54,000 0.0% of portfolio	17,949	Q4 2024 New
SANA Sana Biotechnology, Inc.	$493M	$46,000 0.0% of portfolio	28,352	Q4 2024 Reduced 67.47%
FGEN Fibrogen Inc	$37.5M	$45,000 0.0% of portfolio	85,233	Q2 2024 Added 0.09%
ANIX Anixa Biosciences Inc	$94.1M	$44,000 0.0% of portfolio	17,994	Q4 2024 New
FATE Fate Therapeutics Inc	$106M	$43,000 0.0% of portfolio	26,533	Q4 2024 New
LRMR Larimar Therapeutics, Inc.	$129M	$43,000 0.0% of portfolio	11,270	Q4 2024 New
HRTX Heron Therapeutics, Inc.	$243M	$42,000 0.0% of portfolio	27,607	Q4 2024 New
BOLT Bolt Biotherapeutics, Inc.	$18.1M	$39,000 0.0% of portfolio	72,402	Q4 2024 New
PRQR Pro Qr Therapeutics N.V.	$173M	$39,000 0.0% of portfolio	14,580	Q4 2024 New
ALEC Alector, Inc.	$137M	$37,000 0.0% of portfolio	19,953	Q4 2024 Reduced 50.37%
KRON Kronos Bio, Inc.	$54.5M	$35,000 0.0% of portfolio	37,684	Q4 2024 Added 148.94%
ABSI Absci Corp	$375M	$34,000 0.0% of portfolio	13,353	Q4 2024 New
RLYB Rallybio Corp	$23.8M	$34,000 0.0% of portfolio	35,736	Q4 2024 New
IKNA Ikena Oncology, Inc.	$49.7M	$31,000 0.0% of portfolio	18,934	Q4 2024 New
LVTX Lava Therapeutics Nv	$32.2M	$31,000 0.0% of portfolio	31,985	Q4 2024 Added 169.01%
HLVX Hille Vax, Inc.	$60.2M	$28,000 0.0% of portfolio	13,835	Q4 2024 Reduced 63.01%
STTK Shattuck Labs, Inc.	$50.4M	$28,000 0.0% of portfolio	23,727	Q4 2024 Added 3.14%
RAPT Rapt Therapeutics, Inc.	$32.3M	$26,000 0.0% of portfolio	16,635	Q4 2024 New
MRSN Mersana Therapeutics, Inc.	$48.6M	$24,000 0.0% of portfolio	17,084	Q4 2024 New
BDTX Black Diamond Therapeutics, Inc.	$70.5M	$23,000 0.0% of portfolio	11,143	Q4 2024 Reduced 39.48%
RPTX Repare Therapeutics Inc.	$50.3M	$23,000 0.0% of portfolio	18,122	Q4 2024 Added 59.12%
VIGL Vigil Neuroscience, Inc.	$69.8M	$23,000 0.0% of portfolio	13,695	Q4 2024 New
GALT Galectin Therapeutics Inc	$90.9M	$19,000 0.0% of portfolio	16,491	Q4 2024 New
KPTI Karyopharm Therapeutics Inc.	$666M	$19,000 0.0% of portfolio	28,699	Q4 2024 Reduced 40.38%
TPST Tempest Therapeutics, Inc.	$8.54M	$19,000 0.0% of portfolio	23,496	Q4 2024 New
CRBU Caribou Biosciences, Inc.	$70.6M	$17,000 0.0% of portfolio	11,294	Q4 2024 New
NXTC Next Cure, Inc.	$21.4M	$15,000 0.0% of portfolio	20,198	Q4 2024 Added 87.47%
OCGN Ocugen, Inc.	$132M	$15,000 0.0% of portfolio	18,851	Q4 2024 New
VERU Veru Inc.	$41.7M	$12,000 0.0% of portfolio	19,833	Q4 2024 Reduced 21.24%
ATHA Athira Pharma, Inc.	$16.6M	$9,000 0.0% of portfolio	16,458	Q4 2024 Reduced 0.06%
BCAB Bio Atla, Inc.	$11.3M	$7,000 0.0% of portfolio	12,820	Q4 2024 New
ALVR Allovir, Inc.	$885M	$6,000 0.0% of portfolio	16,114	Q4 2024 Added 53.79%
BTAI Bio Xcel Therapeutics, Inc.	$48.5M	$4,000 0.0% of portfolio	11,985	Q4 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	16,359	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.